Lipid Profile in Post-Acute Coronary Syndrome Setting: Lipidic Risk Assessment in Young People beyond LDL-C

G P Aditya1, M A Bari

  • 1Dr Gana Pati Aditya, Assistant Professor, Department of Cardiology, Mymensingh Medical College, Mymensingh, Bangladesh;

Insights

Apolipoprotein B (Apo B) levels are better predictors of acute coronary syndrome (ACS) risk in young adults than traditional lipid profiles. Elevated Apo B identifies individuals at risk, even with normal LDL-C levels.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Clinical Diagnostics

Background:

  • Acute coronary syndrome (ACS) is a significant health concern, particularly in younger populations.
  • Traditional lipid profiles, including LDL-C, may underestimate ACS risk in certain individuals.
  • Apolipoprotein B (Apo B) is a key component of atherogenic lipoproteins and may offer a more sensitive marker for cardiovascular risk.

Purpose of the Study:

  • To investigate the role of Apolipoprotein B (Apo B) in predicting acute coronary syndrome (ACS) in young adults.
  • To compare the predictive value of Apo B with conventional lipid parameters (TC, HDL-C, LDL-C, non-HDL-C) for ACS risk.
  • To determine if Apo B can identify individuals at risk for ACS who have normal LDL-C levels.

Main Methods:

  • A case-control study involving 50 young adults (18-45 years) with their first ACS event and 50 age- and sex-matched healthy controls.
  • Analysis of lipid parameters including total cholesterol (TC), HDL-C, LDL-C, non-HDL-C, and Apolipoprotein B (Apo B).
  • Multivariate analysis was employed to identify independent determinants of ACS.

Main Results:

  • Cases with ACS had significantly lower TC, HDL-C, LDL-C, and non-HDL-C compared to controls.
  • Apo B levels were significantly higher in ACS cases (98.7±25.1 mg/dl) than in controls (77.5±35.2 mg/dl).
  • 50% of ACS cases with hyper Apo B had normal LDL-C levels, indicating underestimation of risk by conventional profiles.
  • Apo B was identified as an independent determinant of ACS in multivariate analysis.
  • Among controls, 46% with high LDL-C also had hyper Apo B, suggesting future ACS risk.

Conclusions:

  • Apolipoprotein B (Apo B) is a more effective predictor of acute coronary syndrome (ACS) risk in young adults than standard lipid profiles.
  • Elevated Apo B levels can identify individuals at risk for ACS, even when LDL-C levels are within the normal range.
  • Measuring Apo B can help assess basal or residual ACS risk in young people, providing insights not obtainable from calculated LDL-C alone.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
421
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
812
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.6K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
709
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
582
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
446